Openfund

CORDIS · AFFIRMO

ATRIAL FIBRILLATION INTEGRATED APPROACH IN FRAIL, MULTIMORBID, AND POLYMEDICATED OLDER PEOPLE

Code
AFFIRMO
Programme
H2020
Call
SC1-BHC-24-2020
Status
SIGNED
Period
2021-05-01 – 2026-10-31
Total cost (whole consortium)5 998 753 €
EU contribution (whole consortium)5 998 753 €
EU contribution to Bulgarian participants146 250 €

Official data · CORDIS · synced 2026-10-17 10:16 · official record

Participants

OrganisationsRoleCountryGrant
AALBORG UNIVERSITETcoordinatorDK809 487 €
THE UNIVERSITY OF MANCHESTERparticipantUK807 738 €
FONDAZIONE PER IL TUO CUORE ONLUSparticipantIT651 000 €
THE UNIVERSITY OF LIVERPOOLparticipantUK621 888 €
KAROLINSKA INSTITUTETparticipantSE506 278 €
UNIVERSITEIT GENTparticipantBE457 500 €
Университет на Муриция (УМу)participantES378 504 €
UNIVERSITA CATTOLICA DEL SACRO CUOREparticipantIT250 512 €
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATAparticipantBE212 441 €
MOVERIM SRLparticipantBE188 645 €
UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA DIN BUCURESTIparticipantRO147 012 €
МЕДИЦИНСКИ УНИВЕРСИТЕТ - ПЛОВДИВparticipantBG146 250 €
UNIVERSITA DEGLI STUDI DI PADOVAparticipantIT143 875 €
FACULTY OF MEDICINE, UNIVERSITY OF BELGRADEparticipantRS140 750 €
ISTITUTO SUPERIORE DI SANITAparticipantIT129 895 €
ONTONIX SRLparticipantIT116 000 €
EUROPEAN UNION GERIATRIC MEDICINE SOCIETY AISBLparticipantBE102 875 €
ADVICE PHARMA GROUP SRLparticipantIT89 914 €
CONSIGLIO NAZIONALE DELLE RICERCHEparticipantIT73 190 €
ARRHYTHMIA ALLIANCEparticipantUK25 000 €

Description

Multimorbidity is a common condition in older age, and can substantially influence individuals’ health and quality of life, making management more difficult. A single-disease approach with fragmented care is still prevalent in current healthcare systems despite multimorbidity representing a heterogeneous spectrum of disease combination(s). On this background, the novel approach underpinning the AFFIRMO project is to focus on clusters of multimorbidity where atrial fibrillation(AF) represents one of the chronic conditions. Improving the management of AF in the context of multimorbidity may benefit individuals on a larger scale, with a holistic approach to optimize clinical management of older AF patients taking into account the multifaceted aspects of individuals’ health, including multimorbidity, polypharmacy, personal preferences, and social context. First, the project aims to identify different clusters of multimorbidity in older patients with AF. Second, AFFIRMO aims to assess the needs of patients, caregivers, and health professionals for the comprehensive management of multimorbidity including AF, and to examine ways of optimizing care and self-management. Third, AFFIRMO will develop, implement and test the effectiveness of a patient-centered approach on older multimorbid AF patients in the clinical practice. We aim to adapt, implement and promote a care pathway, in older patients with multimorbidity. A specific objective will be to develop an interoperable care framework that can facilitate the application of this personalized care pathway, that bridges the continuum between primary and secondary care, with the active involvement of patients with shared decision-making. A further aim will be to model the impact of multimorbidity including AF on healthcare costs and the health economic benefits by the proposed integrated care pathway. Finally, subgroup analyses would assess differences on outcomes of in relation to gender and social inequalities.

Official data · CORDIS · synced 2026-10-17 10:16 · official record · Licence: © European Union, CC BY 4.0 (Commission reuse policy).